ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for CTKB

Stock NameCytek Biosciences Inc
TickerCTKB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS23285D1090
LEI549300K2J28BOC6FBO89

Show aggregate CTKB holdings

News associated with CTKB

15,716 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC bought a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 15,716 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds have also recently added […] - 2025-07-11 04:14:50
Diversified Trust Co Acquires Shares of 24,532 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Diversified Trust Co bought a new stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm bought 24,532 shares of the company’s stock, valued at approximately $98,000. Several other institutional investors and hedge funds also recently made changes to their positions in CTKB. Millennium Management LLC […] - 2025-07-03 05:10:56
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.4% – Time to Buy?
Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) were up 2.4% on Tuesday . The stock traded as high as $3.60 and last traded at $3.48. Approximately 1,129,459 shares traded hands during mid-day trading, an increase of 38% from the average daily volume of 819,132 shares. The stock had previously closed at $3.40. […] - 2025-07-02 02:46:59
Quantinno Capital Management LP Purchases New Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Quantinno Capital Management LP bought a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 14,220 shares of the company’s stock, valued at approximately $92,000. Several other institutional investors have also modified […] - 2025-05-29 06:22:53
Millennium Management LLC Has $5.22 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Millennium Management LLC increased its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 321.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 803,923 shares of the company’s stock after acquiring an additional 613,314 shares during the quarter. Millennium Management […] - 2025-05-29 05:20:53
Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an equal weight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Cytek […] - 2025-05-29 03:00:47
Price T Rowe Associates Inc. MD Purchases 7,686 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Price T Rowe Associates Inc. MD lifted its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 19.5% in the 4th quarter, HoldingsChannel reports. The fund owned 47,189 shares of the company’s stock after purchasing an additional 7,686 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Cytek Biosciences […] - 2025-05-16 04:31:02
The Goldman Sachs Group Issues Pessimistic Forecast for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Get Free Report) had its price objective reduced by equities researchers at The Goldman Sachs Group from $3.50 to $3.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price target would suggest a potential upside of 0.67% […] - 2025-05-14 04:48:57
Voya Investment Management LLC Sells 3,547 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Voya Investment Management LLC cut its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,749 shares of the company’s stock after selling 3,547 shares during the […] - 2025-05-13 05:54:58
Cytek Biosciences (NASDAQ:CTKB) Cut to “Hold” at TD Cowen
TD Cowen cut shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) from a buy rating to a hold rating in a report issued on Friday morning, MarketBeat reports. They currently have $4.00 price objective on the stock. CTKB has been the subject of a number of other research reports. Piper Sandler lowered their target price […] - 2025-05-12 04:38:52
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Legal & General Group Plc
Legal & General Group Plc increased its position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 3.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 313,037 shares of the company’s stock after acquiring an additional 11,346 shares during the period. Legal […] - 2025-04-25 05:16:53
Renaissance Technologies LLC Purchases 251,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Renaissance Technologies LLC grew its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 118.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 462,600 shares of the company’s stock after purchasing an additional 251,000 shares during the quarter. Renaissance Technologies LLC owned about […] - 2025-04-24 04:50:56
Analysts Anticipate SPTM Will Reach $81
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-22 08:05:47
ExodusPoint Capital Management LP Has $503,000 Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
ExodusPoint Capital Management LP reduced its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 35.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,536 shares of the company’s stock after selling 41,706 shares during the quarter. ExodusPoint […] - 2025-04-13 05:29:02
Wellington Management Group LLP Has $9.85 Million Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Wellington Management Group LLP decreased its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 24.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,517,214 shares of the company’s stock after selling 489,925 shares during the […] - 2025-04-10 06:23:16
American Century Companies Inc. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
American Century Companies Inc. boosted its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 10.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 204,745 shares of the company’s stock after buying an additional 19,802 shares during the period. American Century Companies Inc.’s holdings in Cytek […] - 2025-04-10 05:00:50
KLP Kapitalforvaltning AS Purchases Shares of 20,200 Cytek Biosciences, Inc. (NASDAQ:CTKB)
KLP Kapitalforvaltning AS acquired a new position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 20,200 shares of the company’s stock, valued at approximately $131,000. A number of other large investors have also […] - 2025-04-10 04:20:51
Prudential Financial Inc. Purchases 63,600 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Prudential Financial Inc. raised its position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 57.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 173,382 shares of the company’s stock after acquiring an additional 63,600 shares during the period. […] - 2025-04-07 04:42:53
Cibc World Markets Corp Buys Shares of 11,358 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Cibc World Markets Corp purchased a new position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 11,358 shares of the company’s stock, valued at approximately $74,000. Several other large investors also recently made […] - 2025-03-28 06:16:54
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Intech Investment Management LLC
Intech Investment Management LLC boosted its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 114.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,704 shares of the company’s stock after buying an additional 26,567 shares during the quarter. Intech Investment […] - 2025-03-26 07:16:50
Cytek Biosciences (NASDAQ:CTKB) Earns “Overweight” Rating from Stephens
Cytek Biosciences (NASDAQ:CTKB – Get Free Report)‘s stock had its “overweight” rating restated by Stephens in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $6.00 price objective on the stock. Stephens’ target price points to a potential upside of 47.78% from the company’s current price. CTKB has been […] - 2025-03-21 04:42:53
Piper Sandler Issues Pessimistic Forecast for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Get Free Report) had its price objective cut by research analysts at Piper Sandler from $8.50 to $8.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s price objective would indicate a potential upside of 78.97% from the stock’s current price. […] - 2025-03-06 05:27:22
Cytek Biosciences, Inc. (NASDAQ:CTKB) Stake Boosted by Principal Financial Group Inc.
Principal Financial Group Inc. increased its position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 0.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 506,925 shares of the company’s stock after purchasing an additional 3,753 shares during the period. Principal Financial Group Inc.’s holdings in Cytek Biosciences were worth $3,290,000 as […] - 2025-03-05 07:04:59

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CTKB holdings

DateNumber of CTKB Shares HeldBase Market Value of CTKB SharesLocal Market Value of CTKB SharesChange in CTKB Shares HeldChange in CTKB Base ValueCurrent Price per CTKB Share HeldPrevious Price per CTKB Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CTKB by Blackrock for IE00B3VWM098

Show aggregate share trades of CTKB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-574.0104.095 4.086USD -233 4.43 Profit of 19 on sale
2025-08-06SELL-1183.8903.975 3.966USD -468 4.44 Profit of 56 on sale
2025-08-04SELL-1183.8403.860 3.858USD -455 4.45 Profit of 70 on sale
2025-07-31BUY1773.6003.605 3.605USD 638 4.46
2025-07-28SELL-593.7503.780 3.777USD -223 4.47 Profit of 41 on sale
2025-07-25SELL-593.6903.710 3.708USD -219 4.48 Profit of 45 on sale
2025-06-30SELL-1183.4003.620 3.598USD -425 4.61 Profit of 119 on sale
2025-06-25SELL-593.3303.375 3.370USD -199 4.63 Profit of 74 on sale
2025-06-20SELL-1182.9503.130 3.112USD -367 4.66 Profit of 183 on sale
2025-05-23BUY592.4202.455 2.451USD 145 4.90
2025-05-19SELL-592.6902.710 2.708USD -160 4.98 Profit of 134 on sale
2025-05-15SELL-1772.6802.760 2.752USD -487 5.01 Profit of 400 on sale
2025-05-12SELL-1183.0203.160 3.146USD -371 5.06 Profit of 226 on sale
2025-04-30SELL-593.7103.750 3.746USD -221 5.16 Profit of 84 on sale
2025-04-24SELL-1183.8203.820 3.820USD -451 5.21 Profit of 164 on sale
2025-04-17SELL-593.6503.680 3.677USD -217 5.28 Profit of 95 on sale
2025-04-15SELL-1773.7203.790 3.783USD -670 5.31 Profit of 271 on sale
2025-04-14SELL-1773.7603.795 3.792USD -671 5.33 Profit of 272 on sale
2025-04-09SELL-2363.7403.820 3.812USD -900 5.38 Profit of 370 on sale
2025-04-07SELL-4133.6703.940 3.913USD -1,616 5.42 Profit of 621 on sale
2025-04-04SELL-5903.7103.750 3.746USD -2,210 5.43 Profit of 996 on sale
2025-03-31BUY594.0104.065 4.060USD 240 5.48
2025-03-19SELL-1184.2204.325 4.314USD -509 5.61 Profit of 153 on sale
2025-03-14SELL-3604.2004.220 4.218USD -1,518 5.66 Profit of 518 on sale
2025-03-13SELL-1204.1404.205 4.198USD -504 5.67 Profit of 177 on sale
2025-03-12SELL-2,0404.1704.290 4.278USD -8,727 5.69 Profit of 2,887 on sale
2025-03-07SELL-1204.5304.570 4.566USD -548 5.74 Profit of 141 on sale
2025-03-06SELL-1804.4604.519 4.513USD -812 5.76 Profit of 224 on sale
2025-03-03SELL-604.3004.580 4.552USD -273 5.82 Profit of 76 on sale
2025-02-28SELL-3604.4904.640 4.625USD -1,665 5.83 Profit of 435 on sale
2025-02-26SELL-605.0005.240 5.216USD -313 5.86 Profit of 39 on sale
2025-02-25SELL-1805.1305.280 5.265USD -948 5.87 Profit of 109 on sale
2025-02-18BUY3005.3105.420 5.409USD 1,623 5.93
2025-02-13BUY605.2205.360 5.346USD 321 5.96
2025-02-12BUY605.2005.290 5.281USD 317 5.98
2025-02-11BUY1805.2005.220 5.218USD 939 5.99
2025-02-06BUY5405.6105.680 5.673USD 3,063 6.02
2025-01-27BUY605.7305.890 5.874USD 352 6.10
2025-01-22SELL-1205.7705.990 5.968USD -716 6.12 Profit of 18 on sale
2025-01-17SELL-605.4605.600 5.586USD -335 6.16 Profit of 34 on sale
2025-01-16BUY605.4905.838 5.803USD 348 6.17
2025-01-14BUY1807.2607.300 7.296USD 1,313 6.16
2025-01-13BUY1207.2107.290 7.282USD 874 6.13
2025-01-08BUY3606.8306.890 6.884USD 2,478 6.07
2024-12-30BUY3006.5506.828 6.800USD 2,040 6.04
2024-12-06BUY2406.4706.850 6.812USD 1,635 5.98
2024-12-05BUY606.5406.770 6.747USD 405 5.96
2024-12-04BUY3006.6906.805 6.793USD 2,038 5.93
2024-11-29BUY3006.5306.610 6.602USD 1,981 5.84
2024-11-27BUY2406.5006.560 6.554USD 1,573 5.78
2024-11-26BUY606.4106.630 6.608USD 396 5.75
2024-11-21BUY2956.4606.540 6.532USD 1,927 5.62
2024-11-20BUY1776.1306.300 6.283USD 1,112 5.60
2024-11-18BUY7086.0306.100 6.093USD 4,314 5.54
2024-11-12BUY4727.0407.230 7.211USD 3,404 5.43
2024-11-08BUY2957.0507.050 7.050USD 2,080 5.32
2024-11-07BUY1,0037.2207.630 7.589USD 7,612 5.17
2024-10-31BUY594.9454.990 4.985USD 294 4.90
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CTKB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19132,3730251,12552.7%
2025-09-18142,2170265,46553.6%
2025-09-17152,9050342,35944.7%
2025-09-16127,0540243,64252.1%
2025-09-15140,8710314,41444.8%
2025-09-12195,9290437,28044.8%
2025-09-11150,2430292,93651.3%
2025-09-10136,0480310,48743.8%
2025-09-09123,923400287,74143.1%
2025-09-08117,8261,000293,59340.1%
2025-09-0596,5060218,17644.2%
2025-09-0466,5020209,42231.8%
2025-09-03214,8040384,14955.9%
2025-09-02148,0441351,75642.1%
2025-08-29148,2230319,37746.4%
2025-08-28174,0170454,80338.3%
2025-08-27103,9170231,62144.9%
2025-08-26191,7610363,86852.7%
2025-08-25141,3461198,11271.3%
2025-08-22129,0760229,67956.2%
2025-08-21120,840560195,20461.9%
2025-08-2069,0160144,85247.6%
2025-08-1999,9717,721162,42661.5%
2025-08-1878,4902142,87154.9%
2025-08-15108,4552215,91050.2%
2025-08-14227,289500363,08562.6%
2025-08-13136,133890492,73227.6%
2025-08-12196,6790468,10742.0%
2025-08-11320,8000570,57456.2%
2025-08-08293,4200431,63568.0%
2025-08-07256,60112,953430,24059.6%
2025-08-06340,7590516,72465.9%
2025-08-05197,8420452,22643.7%
2025-08-04222,8320496,23144.9%
2025-08-01302,2660591,54251.1%
2025-07-31186,4070443,49642.0%
2025-07-30281,4842561,15350.2%
2025-07-29146,3150286,13151.1%
2025-07-28185,5980431,33143.0%
2025-07-25392,5863,900602,26065.2%
2025-07-24104,0470185,05756.2%
2025-07-23119,8272,300227,58852.7%
2025-07-2280,4455,658187,16943.0%
2025-07-2153,928195,81556.3%
2025-07-18116,0190196,22659.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy